|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
7.70/12.03
|
Enterprise Value
56.24B
|
Balance Sheet |
Book Value Per Share
36.83
|
Cash Flow |
Cash Flow Yield
0.06
|
Income Statement |
Total Revenue
14.98B
|
Operating Revenue Per Share
65.90
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/09/28 16:06 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |